Literature DB >> 23408430

Unusual galactofuranose modification of a capsule polysaccharide in the pathogenic yeast Cryptococcus neoformans.

Christian Heiss1, Michael L Skowyra, Hong Liu, J Stacey Klutts, Zhirui Wang, Matthew Williams, Deepa Srikanta, Stephen M Beverley, Parastoo Azadi, Tamara L Doering.   

Abstract

Galactofuranose (Galf) is the five-membered ring form of galactose. Although it is absent from mammalian glycans, it occurs as a structural and antigenic component of important cell surface molecules in a variety of microbes, ranging from bacteria to parasites and fungi. One such organism is Cryptococcus neoformans, a pathogenic yeast that causes lethal meningoencephalitis in immunocompromised individuals, particularly AIDS patients. C. neoformans is unique among fungal pathogens in bearing a complex polysaccharide capsule, a critical virulence factor reported to include Galf. Notably, how Galf modification contributes to the structure and function of the cryptococcal capsule is not known. We have determined that Galf is β1,2-linked to an unusual tetrasubstituted galactopyranose of the glucuronoxylomannogalactan (GXMGal) capsule polysaccharide. This discovery fills a longstanding gap in our understanding of a major polymer of the cryptococcal capsule. We also engineered a C. neoformans strain that lacks UDP-galactopyranose mutase; this enzyme forms UDP-Galf, the nucleotide sugar donor required for Galf addition. Mutase activity was required for the incorporation of Galf into glucuronoxylomannogalactan but was dispensable for vegetative growth, cell integrity, and virulence in a mouse model.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23408430      PMCID: PMC3630864          DOI: 10.1074/jbc.M112.441998

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  71 in total

Review 1.  HIV-associated cryptococcal meningitis.

Authors:  Joseph N Jarvis; Thomas S Harrison
Journal:  AIDS       Date:  2007-10-18       Impact factor: 4.177

2.  Phenotypic switching in Cryptococcus neoformans results in changes in cellular morphology and glucuronoxylomannan structure.

Authors:  B C Fries; D L Goldman; R Cherniak; R Ju; A Casadevall
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

Review 3.  Intracellular parasitism of macrophages by Cryptococcus neoformans.

Authors:  M Feldmesser; S Tucker; A Casadevall
Journal:  Trends Microbiol       Date:  2001-06       Impact factor: 17.079

4.  Capsular polysaccharides galactoxylomannan and glucuronoxylomannan from Cryptococcus neoformans induce macrophage apoptosis mediated by Fas ligand.

Authors:  Suellen N Villena; Roberta O Pinheiro; Carla S Pinheiro; Marise P Nunes; Cristina M Takiya; George A DosReis; José O Previato; Lucia Mendonça-Previato; Célio G Freire-de-Lima
Journal:  Cell Microbiol       Date:  2008-01-30       Impact factor: 3.715

Review 5.  Lectins as pattern recognition molecules: the effects of epitope density in innate immunity.

Authors:  Tarun K Dam; C Fred Brewer
Journal:  Glycobiology       Date:  2009-11-24       Impact factor: 4.313

Review 6.  Galactofuranose containing molecules in Aspergillus fumigatus.

Authors:  Jean-Paul Latge
Journal:  Med Mycol       Date:  2008-08-05       Impact factor: 4.076

7.  Structure determination of Cryptococcus neoformans serotype A-variant glucuronoxylomannan by 13C-n.m.r. spectroscopy.

Authors:  R Cherniak; R G Jones; E Reiss
Journal:  Carbohydr Res       Date:  1988-01-15       Impact factor: 2.104

8.  The structure of Cryptococcus neoformans galactoxylomannan contains beta-D-glucuronic acid.

Authors:  Christian Heiss; J Stacey Klutts; Zhirui Wang; Tamara L Doering; Parastoo Azadi
Journal:  Carbohydr Res       Date:  2009-03-10       Impact factor: 2.104

9.  Galactoxylomannans from Cryptococcus neoformans varieties neoformans and grubii are structurally and antigenically variable.

Authors:  Magdia De Jesus; Siu-Kei Chow; Radames J B Cordero; Susana Frases; Arturo Casadevall
Journal:  Eukaryot Cell       Date:  2010-01-08

10.  Toward an integrated model of capsule regulation in Cryptococcus neoformans.

Authors:  Brian C Haynes; Michael L Skowyra; Sarah J Spencer; Stacey R Gish; Matthew Williams; Elizabeth P Held; Michael R Brent; Tamara L Doering
Journal:  PLoS Pathog       Date:  2011-12-08       Impact factor: 6.823

View more
  17 in total

Review 1.  Cryptococcus neoformans and Cryptococcus gattii, the etiologic agents of cryptococcosis.

Authors:  Kyung J Kwon-Chung; James A Fraser; Tamara L Doering; Zhou Wang; Guilhem Janbon; Alexander Idnurm; Yong-Sun Bahn
Journal:  Cold Spring Harb Perspect Med       Date:  2014-07-01       Impact factor: 6.915

2.  Structure elucidation of a galactofuranose-rich heteropolysaccharide from aciduric fungus penicillium purpurogenum JS03-21.

Authors:  Yin Chen; Wenjun Mao; Hui Wang; Weiming Zhu; Qingfeng Niu; Xubo Fang; Tao Li
Journal:  Glycoconj J       Date:  2015-01-25       Impact factor: 2.916

3.  Pbx proteins in Cryptococcus neoformans cell wall remodeling and capsule assembly.

Authors:  Pardeep Kumar; Christian Heiss; Felipe H Santiago-Tirado; Ian Black; Parastoo Azadi; Tamara L Doering
Journal:  Eukaryot Cell       Date:  2014-02-28

4.  Cryptococcus neoformans UGT1 encodes a UDP-Galactose/UDP-GalNAc transporter.

Authors:  Lucy X Li; Angel Ashikov; Hong Liu; Cara L Griffith; Hans Bakker; Tamara L Doering
Journal:  Glycobiology       Date:  2016-08-03       Impact factor: 4.313

5.  Cryptococcus neoformans dual GDP-mannose transporters and their role in biology and virulence.

Authors:  Zhuo A Wang; Cara L Griffith; Michael L Skowyra; Nichole Salinas; Matthew Williams; Ezekiel J Maier; Stacey R Gish; Hong Liu; Michael R Brent; Tamara L Doering
Journal:  Eukaryot Cell       Date:  2014-04-18

6.  Identification of the galactosyltransferase of Cryptococcus neoformans involved in the biosynthesis of basidiomycete-type glycosylinositolphosphoceramide.

Authors:  Therese Wohlschlager; Reto Buser; Michael L Skowyra; Brian C Haynes; Bernard Henrissat; Tamara L Doering; Markus Künzler; Markus Aebi
Journal:  Glycobiology       Date:  2013-08-06       Impact factor: 4.313

Review 7.  Unraveling synthesis of the cryptococcal cell wall and capsule.

Authors:  Zhuo A Wang; Lucy X Li; Tamara L Doering
Journal:  Glycobiology       Date:  2018-10-01       Impact factor: 4.313

8.  Macrophage Cryptococcus interactions: an update.

Authors:  Michael K Mansour; Jennifer L Reedy; Jenny M Tam; Jatin M Vyas
Journal:  Curr Fungal Infect Rep       Date:  2014-03-01

Review 9.  Cryptococcus neoformans: historical curiosity to modern pathogen.

Authors:  Deepa Srikanta; Felipe H Santiago-Tirado; Tamara L Doering
Journal:  Yeast       Date:  2014-01-19       Impact factor: 3.239

10.  Xylose donor transport is critical for fungal virulence.

Authors:  Lucy X Li; Carsten Rautengarten; Joshua L Heazlewood; Tamara L Doering
Journal:  PLoS Pathog       Date:  2018-01-18       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.